The World Health Organization (WHO) Prequalification Team (PQT) - Medicines will be attending the Mumbai CPhI from 28 to 30 November 2017, in Mumbai, India.
For most international procurement agencies, WHO prequalification or stringent regulatory approval is a prerequisite when applying for medicine tender contracts. WHO-prequalified finished pharmaceutical products (FPPs) and active pharmaceutical ingredients (APIs) are publicly listed and recognized as meeting international quality and good manufacturing practice requirements. Increasingly, the prequalification status of an FPP and API is accepted by national regulatory authorities in Africa and leads to faster registration.
The focus of the WHO Prequalification Team – Medicines (PQT-Medicines) is medicines and APIs needed for treating high-burden diseases such as HIV/AIDS, hepatitis C, malaria, tuberculosis, and neglected tropical diseases - and for reproductive health.
A complete list of APIs and FPPs invited for prequalification can be viewed at: https://extranet.who.int/prequal/content/prequalified-lists/medicines
PQT Medicines will be presenting at the CPhI Bombay Exhibition Grounds on 30 November from 13:15 to 15:00.
One on One meetings with manufacturers
PQT Medicines will also be offering the opportunity for manufacturers to meet with PQT Medicines assessment and inspection staff at the nearby Westin Mumbai Garden City Hotel on 28 November (10:00 - 17:00) and 29 November (09:00 - 17:00) to answer questions regarding FPP and API prequalification procedures.
Companies who would like to arrange a fac-to-face meeting, should first request a meeting via email to:
“All 1 on 1 meeting times have now been assigned”
For further information, please contact Dr Antony Fake at: email@example.com